Skip to content
Quebec News Tribune – Lifestyle
Author:
ASCENTAGE PHARMA GROUP INTERNATIONAL
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
June 14, 2026
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
May 31, 2026
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
May 31, 2026
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
May 31, 2026
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
May 21, 2026
←
Previous Page
1
2